Marien O. den Boer

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 562 citations

Surgical Oncology, Chemotherapy Versus Chemoradiotherapy, Gastrointestinal Oncology +8

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

Vivianne C. G. Tjan‐Heijnen, Irene E.G. van Hellemond, Petronella G.M. Peer et al. · The Lancet Oncology · 2017 · 157 citations

Medicine, Clinical Trials, Gynecology +10

Mediation of 5‐hydroxytryptamine‐induced tachycardia in the pig by the putative 5‐HT₄ receptor

Carlos M. Villalón, Marien O. den Boer, Jan P.C. Heiligers et al. · British Journal of Pharmacology · 1990 · 120 citations · Full text

Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5‐HT₄ receptor mediating tachycardia in the pig

Carlos M. Villalón, Marien O. den Boer, Jan P.C. Heiligers et al. · British Journal of Pharmacology · 1991 · 68 citations · Full text

Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment

Dave E. W. van der Kruijssen, Sjoerd G. Elias, Geraldine R. Vink et al. · JAMA Surgery · 2021 · 51 citations · Full text